Elsevier

Antiviral Research

Volume 27, Issue 3, June 1995, Pages 271-279
Antiviral Research

Research article
Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV

https://doi.org/10.1016/0166-3542(95)00007-9Get rights and content

Abstract

Penciclovir has potent antiviral activity against varicella-zoster virus (VZV). We have characterized the inhibitory effects of penciclovir and acyclovir on the plaque formation of cell-free VZV and cross-resistance of acyclovir-resistant VZV to penciclovir. The apparent effective concentration for 50% plaque reduction (EC50) of penciclovir determined on the third day was significantly lower than that determined on the fourth or fifth day. The size of plaques was smaller in the presence of penciclovir than in the presence of acyclovir. The effective concentrations for 50% reduction of the number of infected cells per plaque were 1.40 and 5.00 μg/ml for penciclovir and acyclovir, respectively. Thus penciclovir suppressed spread of infection within developing plaques more efficiently than acyclovir. Five acyclovir-resistant VZV strains with altered DNA polymerase selected by acyclovir were examined for cross-resistance to penciclovir. They were 11- to 18-fold more resistant to ACV than the parent strain, but only 4- to 5-fold more resistant to PCV. Penciclovir-triphosphate carrying the 3′-hydroxyl group of 2′-deoxyribose might have better affinity to the altered viral DNA polymerase than acyclovir-triphosphate without the 3′-hydroxyl group.

References (31)

  • Y.J. Bryson et al.

    In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside

    Antimicrob. Agents Chemother.

    (1976)
  • C.S. Crumpacker et al.

    Growth inhibition by acycloguanosine of herpesviruses isolated from human infection

    Antimicrob. Agents Chemother.

    (1979)
  • D.L. Earnshaw et al.

    Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2 and varicella-zoster virus

    Antimicrob. Agents Chemother.

    (1992)
  • G.B. Elion et al.

    Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine

  • H. Field et al.

    The sensitivity of acyclovir resistant mutants of herpes simplex virus to other antiviral drugs

    J. Infect. Dis.

    (1981)
  • Cited by (0)

    View full text